For nearly 50 years, Hodgson has illuminated the synchrotron radiation community through his pioneering research, innovations, leadership, advocacy and mentorship at the Stanford Synchrotron Radiation Lightsource.

Alimohamadi is being recognized for her novel integration of theoretical and experimental results to connect diverse health outcomes with cell membrane behavior.

The results, which show how the protein adds nucleotides to the growing RNA chain, could lead to more effective medications.

Wheat and other sources of gluten can spell trouble for people with the disease, but new findings could aid the development of first-ever drugs for the autoimmune disorder.

Researchers figured out how to spray and freeze a cell sample in its natural state in milliseconds, helping them capture basic biological processes in unprecedented detail.

Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.

Disabling those hinges could be a good strategy for designing vaccines and treatments against a broad range of coronavirus infections.

A   swap of metals and a mutation ramp up the electric field strength at the active site of an enzyme, making it   works an astonishing 50 times faster than its unmodified analog.  

Developing a new, light-activated method to produce the molecule opens doors for future biomedical applications.

An international team has uncovered details about the formation of DNA's building blocks, paving the way  for potential medical and therapeutic applications.

Scientists developed a new method to unlock the secrets of RNA. The implications are wide-reaching, from better understanding diseases to designing new therapeutics. 

Peter Dahlberg has combined two complex imaging techniques into one. The 2021 Panofsky Fellow adds cryo-ET and biosensors to fluorescence microscopy to give context to high-resolution images of individual proteins in cells.